- Home
- IPHA vs SXTC Comparison
IPHA vs SXTC Comparison
Compare IPHA & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | SXTC |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | France | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 177.7M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | IPHA | SXTC |
|---|---|---|
| Price | $1.70 | $0.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 26.6K | ★ 20.7M |
| Earning Date | 09-17-2025 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,839,695.00 | $1,537,987.00 |
| Revenue This Year | $22.29 | N/A |
| Revenue Next Year | $43.90 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.63 | $0.09 |
| 52 Week High | $2.63 | $7.84 |
Technical Indicators
Market Signals| Indicator | IPHA | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 23.92 |
| Support Level | $1.72 | $1.61 |
| Resistance Level | $1.86 | $6.98 |
| Average True Range (ATR) | 0.08 | 0.61 |
| MACD | 0.01 | -0.17 |
| Stochastic Oscillator | 39.39 | 0.06 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.